PHOENIX – August 7, 2018 /Canna Newswire/ – According to, the excitement around Cannabidiol (CBD) and its many health benefits is steadily increasing worldwide. Scientific and clinical research worldwide underscores the potential of CBD as a treatment for a wide range of conditions including arthritis, diabetes, alcoholism, MS, chronic pain, schizophrenia, PTSD, depression, antibiotic-resistant infections, epilepsy, and other neurological disorders. CBD has demonstrable neuroprotective and neurogenic effects, and its anti-cancer properties are currently being investigated at several academic research centers in the United States and elsewhere.

While the possibilities surrounding the health benefits of CBD is incredibly exciting, there are some inherent challenges to overcome. Bioavailability of cannabinoid molecules has improved significantly over the last decade with the advent of nano-emulsion delivery. However, degrees of efficacy vary based upon the methods used to encapsulate CBD. Few technologies have overcome problems of nutrient degradation due to:

  • Decomposition at many levels in the digestive system
  • Immune response of white blood cells, which occurs upon absorption through intestinal walls
  • Hydrolysis (breakdown of molecules upon exposure to fluid) upon entry into the blood stream

To overcome these issues, Cannasphere Biotech has just introduced its leading edge , patent pending liposomal technology called Lipofusion™. This new delivery technology addresses many of the common barriers to bioavailability of actives (such as those mentioned above).

While liposomal delivery is not new, not all methods are equally effective. According to Jim Yiannios, Cannasphere’s chief scientific officer, “Our proprietary patent pending dual encapsulation process encases CBD actives within phospholipids that are bioidentical to the membranes that surround human cells. This allows the liposomes to easily penetrate on a cellular level. The results? Maximized bioavailability and extended absorption time—not to mention increased shelf life.”

“This is all very exciting, but there are other significant advantages of our Lipofusion™ technology. This unique liposomal process makes our CBD powder water soluble while also concealing the unpalatable taste of CBD and other actives inside a double layer membrane of brain-boosting lipids. Not only does this enhance the potential health benefits of CBD products made with our technology, it also means that CBD products made with Lipofusion™ are easy and even enjoyable to take as they can be flavorless or flavored,” says Yiannios.

“How about an all-natural passion fruit CBD beverage to start your day off on the right foot?”

Cannasphere’s Lipofusion™ CBD Powder is hemp-derived, water soluble, broad spectrum, and has no detectable THC. It’s now available in bulk as a raw ingredient, which can be used in a variety of products, such as beverage powders, capsules, tablets, and more.

According to a 2017 report by the market research firm Brightfield Group, hemp-derived CBD will be a $1 billion market by 2020. The Hemp Business Journal reports that hemp-based CBD products have seen a 53% annual growth rate, and that the total hemp market’s five-year compound annual growth rate of 22 percent actually outpaces that of marijuana at 16 percent.

These market projections are enough to turn the heads of any health and wellness products business, but competition is cropping up as fast as consumer demand.

According to Yiannios that is exactly why Cannasphere’s Lipofusion™ technology will be a game changer for product brands, distributors and retailers who wish to offer CBD products that are truly effective and taste great.

About Cannasphere Biotech
Cannasphere Biotech combines the power of Cannabidiol (CBD) with its proprietary leading edge Lipofusion™ delivery technology to maximize efficacy and deliver remarkable, reliable benefits. The company offers raw Lipofusion™ CBD powder and a variety of private-label CBD products, which are sold through select Wholesale Partners around the globe. For more information please visit

Note: All phytocannabinoid-rich (PCR) hemp-derived products produced or manufactured by Cannasphere Biotech, LLC are either imported legally and/or derived from 100% federally legal agricultural hemp produced in compliance with the 2014 US Farm Bill §7606.

# # #

Media Contact:
Kelly Wood
KWPR Group, Inc.

Keep Your Finger on The Pulse

Enter your email address to subscribe to our “CBD Pulse” newsletter!

[wpforms id=”60″ title=”false” description=”true”]

*FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE: These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. CBD drug interaction and side effect documentation is limited. Check with your healthcare practitioner for additional guidance. We highly recommend always checking with your physician before starting a new botanical extract, medicinal herb, or dietary supplement program.